Business
PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner
Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease NetworkMENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global rare disease genomics program of Genetic Alliance, to integrate PacBio’s HiFi® long-read whole-genome sequencing into iHope’s international network. iHope operates the wor
About this update from Pacific Biosciences Of California, Inc.
[{"type":"image","alt":"PacBio","displaySize":"","headline":null,"caption":"PacBio","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":263,"url":"https://media.zenfs.com/en/globenewswire.com/ca3b97d5b827c8cc2602900e245a01c9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/nO_Xed3UYAG.Z8cezVsIzg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM2ODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ca3b97d5b827c8cc2602900e245a01c9","width":300,"height":263}},"lazy":false},{"type":"text","content":"Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease Network","length":128,"tagName":"p"},{"type":"text","content":"MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global rare disease genomics program of Genetic Alliance, to integrate PacBio’s HiFi® long-read whole-genome sequencing into iHope’s international network.","length":349,"tagName":"p"},{"type":"text","content":"iHope operates the world’s largest equitable rare-disease genomic testing network, supporting more than 1,000 patients annually through 25 clinical sites across 14 countries. The program is designed to enable collaborative, multi-technology support for rare disease patients, bringing together diverse approaches and clinical expertise to address the biological complexity of rare genetic disorders. The addition of PacBio’s HiFi long-read whole-genome sequencing aims to expand the range of genomic insights available across the network, providing data that supports iHope’s mission to ultimately drive more diagnostic clarity.","length":628,"tagName":"p"},{"type":"text","content":"“We've been impressed with the progress iHope has made in getting answers for rare disease patients through the use of genomics and we believe HiFi Long-Read WGS can move the needle even more by finding variants that may have been otherwise missed,” said Christian Henry, President and Chief Executive Officer, PacBio. “HiFi long-read sequencing offers a complete view of the genome, and through this collaboration we aim to help expand iHope’s access to more comprehensive and advanced genomic research technologies that may help support its delivery of precision care. As February is Rar...